Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
41 studies found for:    "Ocular melanoma"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Study of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Gemcitabine;   Drug: Treosulfan
2 Active, not recruiting STA-9090(Ganetespib) in Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Intervention: Drug: STA-9090
3 Recruiting Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Sorafenib;   Device: Radioembolization with SIR-Spheres® (Yttrium Microspheres)
4 Recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma
Conditions: Metastatic Ocular Melanoma;   Metastatic Uveal Melanoma
Interventions: Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Young TIL
5 Withdrawn Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
Condition: Ocular Melanoma
Interventions: Drug: Pegylated Interfon Alpha 2B;   Drug: Placebo
6 Completed Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Conditions: Ocular Melanoma;   Choroidal Melanoma;   Uveal Melanoma
Intervention:
7 Recruiting Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Vorinostat
8 Active, not recruiting Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Iris Melanoma;   Medium/Large Size Posterior Uveal Melanoma;   Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma;   Small Size Posterior Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Drug: Selumetinib;   Drug: Temozolomide
9 Recruiting Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
10 Completed THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
Condition: Ocular Melanoma
Intervention: Drug: Ipilimumab
11 Not yet recruiting Definity for Ultrasound of Intraocular Tumors
Condition: Ocular Melanoma
Intervention: Device: Microbubble contrast agent
12 Recruiting Cytogenetic Study of Ocular Melanoma
Condition: Choroidal Melanoma
Intervention:
13 Completed
Has Results 		Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Revlimid
14 Completed A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
Condition: Melanoma
Intervention: Procedure: Laparotomy
15 Recruiting The Role of Inflammation in Ocular Tumours
Condition: Ocular Melanoma
Intervention: Other: cSLO imaging
16 Not yet recruiting Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Conditions: Metastatic Malignant Neoplasm in the Brain;   Metastatic Melanoma;   Mucosal Melanoma;   Ocular Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Radiation: Stereotactic Radiosurgery
17 No longer available Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Conditions: Metastatic Liver Cancer;   Ocular Melanoma;   Cutaneous Melanoma
Interventions: Drug: Melphalan;   Device: Percutaneous Hepatic Perfusion
18 Active, not recruiting CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma
Conditions: Carcinoma of Unknown Primary Origin;   Iris Melanoma;   Medium/Large Size Posterior Uveal Melanoma;   Mucosal Melanoma;   Ocular Melanoma With Extraocular Extension;   Small Size Posterior Uveal Melanoma;   Stage IIB Skin Melanoma;   Stage IIB Uveal Melanoma;   Stage IIC Skin Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Skin Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Skin Melanoma;   Stage IV Uveal Melanoma
Interventions: Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401;   Other: Laboratory Biomarker Analysis;   Biological: Neoantigen-based Melanoma-Poly-ICLC Vaccine;   Other: Pharmacological Study;   Biological: Recombinant Flt3 Ligand
19 Terminated Imatinib in Adult Patients With Metastatic Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Imatinib
20 Unknown † Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Condition: Intraocular Melanoma
Interventions: Drug: cisplatin;   Drug: sunitinib malate;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years